Clinical Trial Update: Botulinum Toxin Type A and Modified Constraint-Induced Movement Therapy for Poststroke Upper Extremity Spasticity [NA]

View source ↗

Summary

A completed clinical trial evaluated botulinum toxin type A in combination with Modified Constraint-Induced Movement Therapy for post-stroke upper-extremity spa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Kaohsiung Veterans General Hospital. | Conditions: Stroke | NA | Status: COMPLETED